By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ariad Pharmaceuticals, Inc. 

26 Landsdowne Street

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-494-0400 Fax: 617-494-8144


ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer and other difficult-to-treat cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines. For additional information, visit or follow ARIAD on Twitter (@ARIADPharm).

Key Statistics

Ownership: Public

Web Site: Ariad
Symbol: ARIA

Company News
Ariad (ARIA) To Present At The Cowen and Company 35th Annual Health Care Conference 2/24/2015 11:05:29 AM
Ariad (ARIA) Confirms Receipt Of Sarissa Capital Management’s Nomination Of Director Candidates 2/20/2015 12:59:02 PM
Ariad (ARIA) Touts Impressive Financials But Investors Still Push for CEO Ouster 2/20/2015 6:38:59 AM
Ariad Pharmaceuticals (ARIA) Reports 2014 Financial Results, Provides 2015 Financial Guidance And Outlines Strategic Objectives 2/19/2015 12:25:11 PM
Activist Fund Wants to Oust Ariad Pharmaceuticals (ARIA) CEO Harvey Berger 2/13/2015 7:36:20 AM
Ariad Pharmaceuticals, Inc. (ARIA) To Present At The RBC Capital Markets’ Healthcare Conference 2/11/2015 12:47:18 PM
Ariad Pharmaceuticals, Inc. (ARIA) To Present At The Leerink Global Healthcare Conference 2/3/2015 12:16:27 PM
Ariad Pharmaceuticals, Inc. (ARIA) To Webcast Conference Call On Fourth Quarter And Year-End 2014 Financial Results 1/29/2015 11:15:43 AM
AstraZeneca PLC (AZN) Rumored to be Stalking Massachusetts's Ariad Pharmaceuticals, Inc. (ARIA) 1/28/2015 12:04:43 PM
Ariad Pharmaceuticals, Inc. (ARIA) Announces Appointment Of Thomas J. DesRosier, Senior Pharmaceutical-Industry Counsel, As Chief Legal And Administrative Officer 1/22/2015 11:03:18 AM